Skip to main content

CD105 expression as a measure of microvessel density in supraglottic laryngeal squamous cell carcinoma

European Archives of Oto-Rhino-Laryngology volume 266, Article number: 1971 (2009) Cite this article

Abstract

The purpose of the present study was to examine the expression of CD105 among patients with supraglottic laryngeal cancer and to assess the clinical relevance of CD105-assessed MVD. A total of 40 patients with supraglottic squamous cell carcinomas (SCCs) were included in the present study. Surgical specimens were immunostained for CD105 and MVD was calculated at 400× magnification. The rounded mean value of the vessel count in four fields for each case was used as the final MVD value. The mean MVD value assessed by CD105 in considered supraglottic SCCs was 13.5 (SD = 3.97). High MVD was significantly correlated with advanced (III and IV) clinical stage (Mann–Whitney U test P = 0.01) and malignancy recurrence presence/absence (Mann–Whitney U test P = 0.023). Spearman’s rank correlation test showed significant correlation between high CD105-assessed MVD and pN+ category (rho = 0.337, P = 0.033), advanced Stage (III and IV) (rho = 0.402, P = 0.01) and developed locoregional recurrence (rho = 0.395, P = 0.012). The logistic regression showed that a high CD105+ MVD was the only independent marker of tumor recurrence (P = 0.029; odds ratio, 6.64; 95% CI, 1.218–36.152). The average MVD was significantly higher in patients with advanced TNM stage and in patients with locoregional recurrence of disease, suggesting that angiogenesis is closely related with clinical aggressiveness of tumor. CD105-assessed MVD in supraglottic laryngeal SSCs may identify patients at risk of recurrence of disease.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

USD 39.95

Price includes VAT (USA)
Tax calculation will be finalised during checkout.

Fig. 1
Fig. 2

References

  1. Hobson B, Denekamp J (1984) Endothelial proliferation in tumors and normal tissues: continuous labelling studies. Br J Cancer 49:405–413

    CAS  PubMed  Google Scholar 

  2. Duff SE, Li C, Garland JM, Kumar S (2003) CD105 is important for angiogenesis: evidence and potential applications. FASEB J 17:984–992. doi:10.1096/fj.02-0634rev

    Article  CAS  PubMed  Google Scholar 

  3. Reinmuth N, Parikh AA, Ahmad SA, Liu W, Stoeltzing O, Fan F, Takeda A, Akagi M, Ellis LM (2003) Biology of angiogenesis in tumors of the gastrointestinal tract. Microsc Res Tech 60:199–207. doi:10.1002/jemt.10258

    Article  CAS  PubMed  Google Scholar 

  4. Pepper MS (1997) Transforming growth factor-β: vasculogenesis, angiogenesis, and vessel wall integrity. Cytokine Growth Factor Rev 8:21–43. doi:10.1016/S1359-6101(96)00048-2

    Article  CAS  PubMed  Google Scholar 

  5. Koleva RI, Conley BA, Romero D, Riley KS, Marto JA, Lux A, Vary CP (2006) Endoglin structure and function: determinants of endoglin phosphorylation by transforming growth factor-β receptors. J Biol Chem 281:25110–25123. doi:10.1074/jbc.M601288200

    Article  CAS  PubMed  Google Scholar 

  6. Kumar S, Ghellal A, Li C, Byrne G, Haboubi N, Wang JM, Bundred N (1999) Breast carcinoma: vascular density determined using CD105 antibody correlates with tumor prognosis. Cancer Res 59:856–861

    CAS  PubMed  Google Scholar 

  7. Massi D, Franchi A, Paglierani M, Ketabchi S, Borgognoni L, Reali UM, Santucci M (2004) Vasculogenic mimicry has no prognostic significance in pT3 and pT4 cutaneous melanoma. Hum Pathol 35:496–502. doi:10.1016/j.humpath.2003.10.022

    Article  CAS  PubMed  Google Scholar 

  8. Saad RS, Liu YL, Nathan G, Celebrezze J, Medich D, Silverman JF (2004) Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in colorectal cancer. Mod Pathol 17:197–203. doi:10.1038/modpathol.3800034

    Article  CAS  PubMed  Google Scholar 

  9. Li SL, Gao DL, Zhao ZH, Liu ZW, Zhao QM, Yu JX, Chen KS, Zhang YH (2007) Correlation of matrix metalloproteinase suppressor genes RECK, VEGF, and CD105 with angiogenesis and biological behavior in esophageal squamous cell carcinoma. World J Gastroenterol 13(45):6076–6081. doi:10.3748/wjg.13.6076

    Article  PubMed  Google Scholar 

  10. Tanaka F, Otake Y, Yanagihara K, Kawano Y, Miyahara R, Li M, Yamada T, Hanaoka N, Inui K, Wada H (2001) Evaluation of angiogenesis in non-small cell lung cancer: comparison between anti-CD34 antibody and anti-CD105 antibody. Clin Cancer Res 7:3410–3415

    CAS  PubMed  Google Scholar 

  11. Salvesen HB, Gulluoglu MG, Stefansson I, Akslen LA (2003) Significance of CD 105 expression for tumour angiogenesis and prognosis in endometrial carcinomas. APMIS 111:1011–1018. doi:10.1111/j.1600-0463.2003.apm1111103.x

    Article  PubMed  Google Scholar 

  12. Wilkstrom P, Lissbrant IF, Stattin P, Egevad L, Bergh A (2002) Endoglin (CD105) is expressed on immature blood vessels and is a marker for survival in prostate cancer. Prostate 51:268–275. doi:10.1002/pros.10083

    Article  Google Scholar 

  13. Yagasaki H, Kawata N, Takimoto Y, Nemoto N (2003) Histopathological analysis of angiogenic factors in renal cell carcinoma. Int J Urol 10:220–227. doi:10.1046/j.0919-8172.2003.00608.x

    Article  PubMed  Google Scholar 

  14. Martone T, Rosso P, Albera R, Migliaretti G, Fraire F, Pignataro L, Pruneri G, Bellone G, Cortesina G (2005) Prognostic relevance of CD105+ microvessel density in HNSCC patient outcome. Oral Oncol 41(2):147–155. doi:10.1016/j.oraloncology.2004.08.001

    Article  CAS  PubMed  Google Scholar 

  15. Kyzas PA, Agnantis NJ, Stefanou D (2006) Endoglin (CD105) as a prognostic factor in head and neck squamous cell carcinoma. Virchows Arch 448(6):768–775. doi:10.1007/s00428-006-0195-4

    Article  CAS  PubMed  Google Scholar 

  16. Pruneri G, Ponzoni M, Ferreri AJ, Decarli N, Tresoldi M, Raggi F, Baldessari C, Freschi M, Baldini L, Goldaniga M, Neri A, Carboni N, Bertolini F, Viale G (2002) Microvessel density, a surrogate marker of angiogenesis, is significantly related to survival in multiple myeloma patients. Br J Haematol 118:817–820. doi:10.1046/j.1365-2141.2002.03654.x

    Article  PubMed  Google Scholar 

  17. Pruneri G, Bertolini F, Baldini L, Valentini S, Goldaniga M, Soligo D, Carboni N, Viale G, Lambertenghi-Deliliers G (2003) Angiogenesis occurs in hairy cell leukaemia (HCL) and in NOD/SCID mice transplanted with the HCL line Bonna-12. Br J Haematol 120:695–698. doi:10.1046/j.1365-2141.2003.04133.x

    Article  PubMed  Google Scholar 

  18. Weidner N, Semple JP, Welch WR, Folkman J (1991) Tumor angiogenesis and metastasis—correlation in invasive breast carcinoma. N Engl J Med 324:1–8

    CAS  PubMed  Google Scholar 

  19. Aebersold DM, Beer KT, Laissue J, Hug S, Kollar A, Greiner RH, Djonov V (2000) Intratumoral microvessel density predicts local treatment failure of radically irradiated squamous cell cancer of the oropharynx. Int J Radiat Oncol Biol Phys 48:17–25. doi:10.1016/S0360-3016(00)00573-3

    Article  CAS  PubMed  Google Scholar 

  20. Gallo O, Masini E, Bianchi B, Bruschini L, Paglierani M, Franchi A (2002) Prognostic significance of cyclooxygenase-2 pathway and angiogenesis in head and neck squamous cell carcinoma. Hum Pathol 33:708–714. doi:10.1053/hupa.2002.125376

    Article  CAS  PubMed  Google Scholar 

  21. Kyzas PA, Cunha IW, Ioannidis JP (2005) Prognostic significance of vascular endothelial growth factor immunohistochemical expression in head and neck squamous cell carcinoma: a meta-analysis. Clin Cancer Res 11:1434–1440. doi:10.1158/1078-0432.CCR-04-1870

    Article  CAS  PubMed  Google Scholar 

  22. Minhajat R, Mori D, Yamasaki F, Sugita Y, Satoh T, Tokunaga O (2006) Organ-specific endoglin (CD105) expression in the angiogenesis of human cancers. Pathol Int 56:717–723. doi:10.1111/j.1440-1827.2006.02037.x

    Article  CAS  PubMed  Google Scholar 

  23. Yang LY, Lu WQ, Huang GW, Wang W (2006) Correlation between CD105 expression and postoperative recurrence and metastasis of hepatocellular carcinoma. BMC Cancer 6:110. doi:10.1186/1471-2407-6-110

    Article  PubMed  Google Scholar 

  24. Marioni G, Gaio E, Giacomelli L, Marchese-Ragona R, Staffieri C, Staffieri A, Marino F (2005) Endoglin (CD105) expression in head and neck basaloid squamous cell carcinoma. Acta Otolaryngol 125:307–311. doi:10.1080/00016480410023047

    Article  CAS  PubMed  Google Scholar 

  25. Marioni G, Ottaviano G, Giacomelli L, Staffieri C, Casarotti-Todeschini S, Bonandini E, Staffieri A, Blandamura S (2006) CD105-assessed micro-vessel density is associated with malignancy recurrence in laryngeal squamous cell carcinoma. Eur J Surg Oncol 32(10):1149–1153. doi:10.1016/j.ejso.2006.08.001

    Article  CAS  PubMed  Google Scholar 

  26. Gu X, Xu Y, Wu H, Xu X (2006) Relationship between CD105 and angiogenesis and biological behaviors in squamous carcinoma of larynx. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 20(3):125–128 (article in Chinese)

    Google Scholar 

  27. Marioni G, D’Alessandro E, Giacomelli L, De Filippis C, Calgaro N, Sari M, Staffieri A, Blandamura S (2006) Maspin nuclear localization is related to reduced density of tumour-associated micro-vessels in laryngeal carcinoma. Anticancer Res 26(6C):4927–4932

    CAS  PubMed  Google Scholar 

  28. Li Q, Zhang B, Peng P (2007) Relevance of Endoglin (CD105) VEGF and p53 with invasion metastasis and prognosis of laryngeal carcinoma. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 21(24):1114–1117 (article in Chinese)

    PubMed  Google Scholar 

  29. Liu Y, Xue X, Wang F (2008) The expressions of TP, MK and CD105 in laryngeal squamous cell carcinoma and their clinical significance. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 22(3):100–103 (article in Chinese)

    PubMed  Google Scholar 

  30. Marioni G, Giacomelli L, D’Alessandro E, Staffieri C, Guzzardo V, Staffieri A, Blandamura S (2008) Laryngeal carcinoma recurrence rate and disease-free interval are related to CD105 expression but not to vascular endothelial growth factor 2 (Flk-1/Kdr) expression. Anticancer Res 28(1B):551–557

    PubMed  Google Scholar 

Download references

Conflict of interest statement

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

  1. Clinic for Otorhinolaryngology and Maxillofacial Surgery, Clinical Center of Montenegro, Ljubljanska bb, 81000, Podgorica, Montenegro

    Elvir Zvrko

  2. Institute for Otorhinolaryngology and Maxillofacial Surgery, School of Medicine, University of Belgrade, Belgrade, Serbia

    Anton Mikic

  3. Center for Pathology and Forensic Medicine, Clinical Center of Montenegro, Podgorica, Montenegro

    Ljiljana Vuckovic

Authors
  1. Elvir Zvrko
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anton Mikic
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ljiljana Vuckovic
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Elvir Zvrko.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Zvrko, E., Mikic, A. & Vuckovic, L. CD105 expression as a measure of microvessel density in supraglottic laryngeal squamous cell carcinoma. Eur Arch Otorhinolaryngol 266, 1971 (2009). https://doi.org/10.1007/s00405-009-0962-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s00405-009-0962-3

Keywords

  • Angiogenesis
  • CD105
  • Mean vascular density
  • Laryngeal carcinoma
  • Prognosis